Metraipolis › archive › dc_889238d0787d
AI-Assisted Pharmaceutical Formulation Design: Comparative Development and Experimental Evaluation of Sustained-Release Lornoxicam Tablets — Europe PMC PMID:42515751
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42515751
- DOI
- 10.3390/ph19071070
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T08:07:19.058Z
- SHA-256 of the archived text
3de2416f5024be236f6640471496ba2c176d0890c540c582e80874715c4970d8- Stable URL of this page
https://metraipolis.com/documento/dc_889238d0787d
How to cite
AI-Assisted Pharmaceutical Formulation Design: Comparative Development and Experimental Evaluation of Sustained-Release Lornoxicam Tablets — Europe PMC PMID:42515751 — Europe PMC (en), https://europepmc.org/article/MED/42515751 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_889238d0787d (Metraipolis archive dc_889238d0787d, sha256 3de2416f5024be236f6640471496ba2c176d0890c540c582e80874715c4970d8)
BibTeX
@misc{dc889238d0787d,
title = {AI-Assisted Pharmaceutical Formulation Design: Comparative Development and Experimental Evaluation of Sustained-Release Lornoxicam Tablets — Europe PMC PMID:42515751},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42515751},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_889238d0787d; sha256 3de2416f5024be236f6640471496ba2c176d0890c540c582e80874715c4970d8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42515751. Agents can read the archived copy with the MCP tool read_document.